Search references for SURINABANT. Phrases containing SURINABANT
See searches and references containing SURINABANT!SURINABANT
Chemical compound
Surinabant (SR147778) is a cannabinoid receptor type 1 antagonist developed by Sanofi-Aventis. It is being investigated as a potential treatment for nicotine
Surinabant
Psychoactive drug from the cannabis plant
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cannabis_(drug)
Medication for pain and fever
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Paracetamol
Psychoactive component of cannabis
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Tetrahydrocannabinol
Genus of flowering plants
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Cannabis
Species of plant
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Kava
Plant species
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Cannabis_sativa
Drug that blocks hallucinogen effects
risks. Cannabinoid CB1 receptor antagonists like rimonabant, drinabant, surinabant, and selonabant have been found to block or reduce the psychoactive effects
Trip_killer
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Effects_of_cannabis
Chemical compound (fatty acid neurotransmitter)
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Anandamide
Cannabis sativa L. (marijuana; hemp) used medicinally
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Medical_cannabis
Endocannabinoid reuptake inhibitor under development for psychiatric disorders
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
SYT-510
Species of plant
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Cannabis_ruderalis
'E-6776' RTI-371 S-444,823 SDB-006 SER-601 SPA-229 SR-144,528 STS-135 Surinabant, also known as 'SR147778' Taranabant, also known as 'MK-0364' Tedalinab
List_of_cannabinoids
Spice and hallucinogen
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Nutmeg_(drug)
THC precursor
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Tetrahydrocannabinolic_acid
Homologue of tetrahydrocannabinol
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Tetrahydrocannabivarin
Species of plant
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Cannabis_indica
Designer drugs
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Synthetic_cannabinoids
Natural bicyclic sesquiterpene
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Caryophyllene
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
A-PBITMO
Biological system of neurotransmitters
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Endocannabinoid_system
Chemical compound
related to potent cannabinoid antagonist drugs such as rimonabant and surinabant. However O-1269 and several related drugs were unexpectedly found to act
O-1269
Compounds found in cannabis
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cannabinoid
Naturally-occurring cannabinoid
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cannabinol
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Palmitoylethanolamide
Medication and supplement
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Pregnenolone_(medication)
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
JWH-018
Mammalian protein found in humans
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Cannabinoid_receptor_1
Specific cannabis extract
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Nabiximols
Active metabolite of paracetamol
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
AM404
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
AM-2201
Group of receptors to cannabinoid compounds
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Cannabinoid_receptor
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Pregnenolone
Synthetic chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cod-THC
Phytocannabinoid discovered in 1940
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cannabidiol
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
MDMB-4en-PINACA
Drug designed to treat obesity
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Orlistat
Compounds that inhibit or block the activity of cannabinoid receptors
although both may have action at mu opioid receptors as well. SR147778 (surinabant), a second generation antagonist, has a longer duration of action than
Cannabinoid receptor antagonist
Cannabinoid_receptor_antagonist
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
2-Arachidonoylglycerol
Minor cannabinoid
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cannabigerol
Synthesis of THC from CBD
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Conversion_of_CBD_to_THC
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
ADB-5'Br-BUTINACA
Isomer of tetrahydrocannabinol
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Δ8-Tetrahydrocannabinol
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Rimonabant
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Honokiol
Proposed mechanism of cannabis compounds
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Entourage_effect
Protein-coding gene in the species Homo sapiens
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
GPR18
Acetate ester of tetrahydrocannabinol (THC)
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
THC-O-acetate
Cannabinoid agonist compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Tetrahydrocannabiphorol
Synthetic cannabinoid
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Nabilone
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Long-term_effects_of_cannabis
Active metabolite of Δ9-THC
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
11-Hydroxy-THC
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Genistein
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cannabichromene
Mammalian protein found in humans
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Fatty-acid_amide_hydrolase_1
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Kaempferol
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cannabicyclol
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
5F-ADB
Main secondary metabolite of THC
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
11-Nor-9-carboxy-THC
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Epicatechin_gallate
Synthetic cannabinoid
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
HU-210
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
JWH-073
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Monlunabant
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Yangonin
Pharmaceutical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
ART26.12
Isomer of tetrahydrocannabinol
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Δ11-Tetrahydrocannabinol
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
ADB-BUTINACA
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Magnolol
Synthetic homologue of THC
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Parahexyl
Semi-sythetic cannabinoid drug
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Hexahydrocannabiphorol
Semi-synthetic cannabinoid derivative drug
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Hexahydrocannabihexol
Investigational substance-related disorder drugs
(JTS-661; MK-0594; VPD-737) – neurokinin NK1 receptor antagonist – alcoholism Surinabant (SR-147778; SR147778) – cannabinoid CB1 receptor antagonist – alcoholism
List of investigational substance-related disorder drugs
List_of_investigational_substance-related_disorder_drugs
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Levonantradol
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
AB-CHMINACA
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Oleoylethanolamide
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
WIN_55,212-2
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Zevaquenabant
Synthetic cannabinoid, designer drug
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
ADB-5'Br-PINACA
Pharmaceutical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Irafamdastat
Surfak surfomer (INN) Surgam Surgicel suricainide (INN) suriclone (INN) surinabant (INN, USAN) Surital suritozole (INN) Surmontil suronacrine (INN) Survanta
List_of_drugs:_Sum–Sz
Chemical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Gallocatechol
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Oleamide
Investigational antipsychotics
(SSR504734) – glycine transporter 1 (GlyT1) inhibitor – schizophrenia [236] Surinabant (SR-147778; SR147778) – cannabinoid CB1 receptor antagonist – psychotic
List of investigational antipsychotics
List_of_investigational_antipsychotics
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
AB-FUBINACA
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
JWH-133
Pharmaceutical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
ONO-1110
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
CP_55,940
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Dimethylheptylpyran
Phytocannabinoid compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Isotetrahydrocannabinol
Pharmaceutical compound
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Selonabant
Mammalian protein found in humans
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Cannabinoid_receptor_2
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
PSNCBAM-1
Pharmaceutical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Dronabinol/palmidrol
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
ADB-CHMINACA
Phytocannabinoid
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Cannabidiorcol
Class of enzymes
212-2 Yangonin Inverse agonists AM-251 INV-202 Monlunabant Rimonabant Surinabant Taranabant TM-38837 Zevaquenabant Antagonists AM-6545 Cannabidiol Cannabigerol
Monoacylglycerol_lipase
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Tetrahydrocannabutol
Synthetic cannabinoid
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
A-CHMINACA
Chemical compound
Rezosicone Rimonabant (SR141716) Rosonabant (E-6776) SLV 319 SR-144,528 Surinabant (SR147778) Taranabant (MK-0364) TC-C 14G TM-38837 VCHSR Voacamine Zevaquenabant
Etrinabdione
travel, tourism, insurance
SURINABANT
SURINABANT
SURINABANT
SURINABANT
SURINABANT
SURINABANT
SURINABANT
SURINABANT
SURINABANT
travel, tourism, insurance